Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception

NCT07222228 is registered in ClinicalTrials.gov with Premier Research as lead sponsor.

NCT NCT07222228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07222228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception
Lead sponsor
Premier Research
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
March 31, 2029
Enrollment
165 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

female contraception, healthy women